These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 15318859
1. Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form. López RA, Romero-Estrella S, Infante-Ramírez L, Méndez-Aquino JS, Berrón-Ruiz P, Morales-Alfaro NA, Vivar R, Carrada E, Rivera-Rendón Mdel R, Sánchez-Guerrero SA. Transfusion; 2004 Sep; 44(9):1344-9. PubMed ID: 15318859 [Abstract] [Full Text] [Related]
5. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing. Shan H, Ren FR, Zhao HY, Zhang YZ, Wen GX, Yao FZ, Gao GJ, Yan LX, Jiang CF, Bai XH, Tiemuer MH, Tu YQ, Zhu FM, Zheng YR, Cui L, Liu CL, Gong XY, Lv QS, Zheng P, Ziermann R, Ness P, Wang JX. Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529 [Abstract] [Full Text] [Related]
6. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test. Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon R. Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670 [Abstract] [Full Text] [Related]
7. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R. Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018 [Abstract] [Full Text] [Related]
8. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group. Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [Abstract] [Full Text] [Related]
9. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region]. Ouzan D, Pesle B, Baldini E, Rimbourg H, Darphin F, Cohen N, Brichetti A, Follana R. Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343 [Abstract] [Full Text] [Related]
10. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M. Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759 [Abstract] [Full Text] [Related]
13. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [Abstract] [Full Text] [Related]
15. A study on the epidemiology of hepatitis C infection among blood donors in Singapore. Wang JE. J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336 [Abstract] [Full Text] [Related]
16. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms. Kleinman SH, Stramer SL, Brodsky JP, Caglioti S, Busch MP. Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836 [Abstract] [Full Text] [Related]